Insider Shareholders with Direct Ownership of Avenue Therapeutics, Inc. (ATXI)
This section provides a comprehensive overview of the insiders with direct ownership of Avenue Therapeutics, Inc. (ATXI). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
AVENUE THERAPEUTICS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Fortress Biotech, Inc.
> 10% Shareholder |
3,308,057 | 0 | 3,547,393 $6.88 Million | 6 |
Apr 16, 2024
Added 10.44%
|
|
Lu Lucy
President, CEO |
411,616 | 0 | 748,949 $1.45 Million | 1 |
Dec 17, 2021
Added 35.47%
|
|
Lindsay A Md Rosenwald
Director |
348,675 | 0 | 354,318 $687,376 | 1 |
Sep 08, 2023
Added 49.6%
|
|
Alexandra Mac Lean
Chief Executive Officer |
170,000 | 0 | 170,000 $329,800 | 1 |
Sep 23, 2024
Added 50.0%
|
|
Joseph Walter Vazzano
Chief Financial Officer |
100,505 | 7,160 | 165,757 $321,568 | 2 |
Dec 17, 2021
Added 37.75%
|
|
David Jin
Interim PFO and COO |
65,000 | 0 | 65,000 $126,100 | 1 |
Sep 23, 2024
Added 50.0%
|
|
Curtis Gale Oltmans
Director |
49,020 | 0 | 49,020 $95,098 | 1 |
Dec 17, 2021
Added 50.0%
|
|
Jay D Kranzler
Director |
69,520 | 61 | 559 $1,084 | 4 |
Nov 05, 2024
Reduced 9.84%
|
|
Neil Herskowitz
Director |
71,520 | 23 | 97 $188 | 3 |
Dec 02, 2024
Reduced 19.17%
|
|
Inva Gen Pharmaceuticals, Inc.
> 10% Shareholder |
0 | 388,888 | 0 $0 | 1 |
Oct 11, 2022
Reduced 100.0%
|
|
Robert L Davidow
> 10% Shareholder |
0 | 264,000 | 0 $0 | 1 |
N/A
|